Sinusitis Board decisions

The Board denied service connection for a right leg condition, sinusitis, lower back condition, and joint pain as the evidence did not support a finding that these conditions began during active service or are otherwise related to an in-service injury, event, or disease.

The Board granted a 10 percent evaluation for the Veteran's service-connected allergic rhinitis, finding that it more nearly approximated nasal obstruction of greater than 50 percent on both sides.

The Board granted an effective date of May 2, 2023, for the award of service connection for non-allergic rhinitis but denied a rating greater than 10 percent.

The Veteran's November 21, 2024 VA Form 20-0996 Request for Higher-Level Review was timely filed and the Board granted it.

The Board denied the veteran's appeal for timely filing of an appeal request, dismissing the attempted appeal.

The Board denied service connection for allergic rhinitis as the evidence of record does not support a finding that the Veteran has or had allergic rhinitis during the pendency of this appeal.

The Board denied service connection for allergic rhinitis as the evidence of record does not support a finding that the Veteran has or had allergic rhinitis during the pendency of this appeal.

The veteran's appeal requests were denied as they were not timely filed, and no good cause was shown to extend the time limit.

The Board remands the claims for chronic sinusitis and migraine headaches to obtain additional medical evidence regarding their relationship to service or other service-connected conditions.

The Board denied the veteran's claims for service connection and increased ratings, finding that the evidence did not support a link between his current conditions and his military service.

The veteran withdrew the appeal, and the Board dismissed all issues related to service connection for allergic rhinitis, obstructive sleep apnea, and chronic respiratory disability.

The Board denied service connection for right shoulder impingement syndrome, allergic rhinitis, bilateral hearing loss, and tinnitus. However, it granted service connection for headaches and remanded the claims for an initial rating in excess of 50 percent for adjustment disorder with mixed anxiety and depressed mood and alcohol use disorder.

The veteran withdrew all pending claims, including those for increased ratings and service connection.

The appeal for a compensable initial rating for allergic rhinitis was dismissed as it had already been decided by the Board based on the same Higher-Level Review rating decision.

The Board remands the claim for an earlier effective date for service connection of chronic sinusitis due to a pre-decisional duty to assist error.

The Board denied the claims for a rating in excess of 30 percent for headaches and an initial compensable rating for sinusitis due to the Veteran's failure to report for scheduled VA examinations without good cause.

The Board remands the issue of entitlement to service connection for sinusitis due to a pre-decisional duty-to-assist error and the need for additional evidence.

The Board denied service connection for allergic rhinitis and chronic fatigue syndrome, granted service connection for obstructive sleep apnea (OSA), and denied service connection for central pain syndrome. The Board also remanded claims for diabetes mellitus type II and hypertension, both to include as secondary to OSA.

The Board granted service connection for a cervical spine condition, right ankle condition, and left ankle condition but denied service connection for sinusitis. The rating for the low back condition was also adjusted.

The Board granted initial ratings of 70 percent for right upper extremity peripheral neuropathy, 60 percent for left upper extremity peripheral neuropathy, and 30 percent each for right and left lower extremity peripheral neuropathy (femoral and sciatic nerves), while denying an increased rating for allergic rhinitis and granting a 10 percent rating for chloracne of the face, arms, and back prior to September 27, 2018.